Stock 000952 HUBEI GUANGJI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
5.9 CNY +2.97% Intraday chart for Hubei Guangji Pharmaceutical Co., Ltd. +7.27% -26.16%
Apr. 25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Hubei Guangji Pharmaceutical Co., Ltd. is the Chinese leader of pharmaceutical ingredients production. The group's activity is organized around four product families:

- vitamins: riboflavin and beta carotene;

- food supplements;

- fine chemistry products;

- medicinal preparations.

Number of employees: 1,256

Sales per Business

CNY in Million2021Weight2022Weight Delta
Raw Material
66.7 %
571 68.2 % 532 66.7 % -6.77%
Others
16.5 %
155 18.5 % 131 16.5 % -15.02%
Preparation
16.5 %
111 13.3 % 131 16.5 % +18.04%
Other Business
0.3 %
0 0.1 % 3 0.3 % +494.89%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
72.8 %
531 63.5 % 581 72.8 % +9.32%
Abroad
27.2 %
306 36.5 % 217 27.2 % -29.10%

Managers

Managers TitleAgeSince
Shu Ruan CEO
 Chief Executive Officer 48 21-04-21
Ming Feng Hu DFI
 Director of Finance/CFO 54 16-09-13
Zheng Dong Lu CTO
 Chief Tech/Sci/R&D Officer 47 -
Bin Zheng BRD
 Director/Board Member 35 20-06-21
Shao Zhi Guo BRD
 Director/Board Member 55 15-01-05
Zhong Yi Ruan PRN
 Corporate Officer/Principal 60 -

Members of the board

Members of the board TitleAgeSince
Qing Yuan Li BRD
 Director/Board Member 47 21-04-21
Shao Zhi Guo BRD
 Director/Board Member 55 15-01-05
Zhong Yi Ruan PRN
 Corporate Officer/Principal 60 -
Ming Feng Hu DFI
 Director of Finance/CFO 54 16-09-13
Bin Zheng BRD
 Director/Board Member 35 20-06-21
Tao Jiang BRD
 Director/Board Member 48 18-01-23
Shu Ruan CEO
 Chief Executive Officer 48 21-04-21
Bo Liu BRD
 Director/Board Member 48 21-04-21
Kui Hong BRD
 Director/Board Member 58 21-04-21
Jian Ming Mei BRD
 Director/Board Member 52 21-04-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 363,834,939 228,704,998 ( 62.86 %) 9,974,000 ( 2.741 %) 62.86 %

Shareholders

NameEquities%Valuation
Cinda Fund Management Co. Ltd.
2.358 %
7,108,753 2.358 % 6 M ¥
Bosera Asset Management Co., Ltd.
0.0804 %
242,400 0.0804 % 197 878 ¥
Huatai-PineBridge Fund Management Co., Ltd.
0.0660 %
198,840 0.0660 % 162 319 ¥
Everbright PGIM Fund Management Co. Ltd.
0.0265 %
80,000 0.0265 % 65 306 ¥
CITIC-Prudential Fund Management Co., Ltd.
0.0232 %
70,000 0.0232 % 57 143 ¥
Jyah Asset Management Co. Ltd.
0.0126 %
37,900 0.0126 % 30 939 ¥
Gfund Management Co., Ltd.
0.000066 %
200 0.000066 % 163 ¥
CICC Fund Management Ltd.
0.000040 %
120 0.000040 % 98 ¥

Company contact information

Hubei Guangji Pharmaceutical Co., Ltd.

1 Jiangdi Road Wuxue

435400, Huanggang

+86 71 3621 9458

http://www.guangjipharm.com
address Hubei Guangji Pharmaceutical Co., Ltd.(000952)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
HUBEI GUANGJI PHARMACEUTICAL CO., LTD. Stock Hubei Guangji Pharmaceutical Co., Ltd.
-26.16% 288M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 290B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000952 Stock
  4. Company Hubei Guangji Pharmaceutical Co., Ltd.